Financhill
Back

Biolase Stock Predictions

Biolase Stock Forecast

  • Is Biolase Stock Undervalued?
    The current Biolase [BIOLQ] share price is $0.0060. The Score for BIOLQ is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • BIOLQ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Biolase Stock Go Up Next Year?

Data Unavailable

Biolase Stock Rating

Data Unavailable

Biolase Stock Price History

Is BIOLQ stock going to rise?

  • The current trend is relatively stagnant and BIOLQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
biolase.com

52-Week Data

52-Week High:
1.8800
52-Week Low:
0.0040

Prediction Charts

Market Cap:
219.6K
Price in USD:
0.0060
Volume:
81.9K
Beta:
1.6221

Technical Analysis

SMA50:
0.0201
SMA100:
0.0421
SMA200:
0.0961
52-Wk Change:
-99.52%

Stock Predictions

  • Is Biolase stock public?
    Yes, Biolase is a publicly traded company.
  • What is the Biolase stock quote today?
    The Biolase stock price is 0.0060 USD today.
  • How to buy Biolase stock online?
    You can buy Biolase shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-7 0.0060 0.0045 0.0060 0.0045
Nov-8 0.0040 0.0040 0.0060 0.0040
Nov-11 0.0040 0.0040 0.0059 0.0040
Nov-12 0.0040 0.0050 0.0060 0.0040
Nov-13 0.0050 0.0050 0.0067 0.0050
Nov-14 0.0068 0.0069 0.0070 0.0050
Nov-15 0.0069 0.0050 0.0069 0.0050
Nov-18 0.0050 0.0050 0.0064 0.0040
Nov-19 0.0050 0.0050 0.0064 0.0050
Nov-20 0.0050 0.0050 0.0050 0.0040
Nov-21 0.0055 0.0050 0.0059 0.0050
Nov-22 0.0050 0.0055 0.0060 0.0050
Nov-25 0.0050 0.0055 0.0055 0.0040
Nov-26 0.0050 0.0060 0.0060 0.0050

Biolase Earnings

Data Unavailable

Biolase Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.40 per share, and an increase next year of $0.24 per share.

* Biolase stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.